ORGANIZATION AND BASIS OF PRESENTATION (Details)
$ / shares in Units, $ in Thousands |
|
|
|
|
|
|
|
|
|
|
1 Months Ended |
12 Months Ended |
|
|
Dec. 01, 2025
USD ($)
$ / shares
shares
|
Sep. 09, 2025
$ / shares
shares
|
Sep. 08, 2025
USD ($)
|
Aug. 07, 2025
USD ($)
$ / shares
shares
|
Feb. 05, 2025
USD ($)
$ / shares
shares
|
Nov. 03, 2024
USD ($)
$ / shares
shares
|
Apr. 25, 2024
USD ($)
$ / shares
shares
|
Jun. 02, 2023
USD ($)
$ / shares
shares
|
May 20, 2022
USD ($)
shares
|
Apr. 28, 2022
USD ($)
$ / shares
shares
|
Dec. 31, 2025
USD ($)
$ / shares
shares
|
Dec. 31, 2025
USD ($)
$ / shares
shares
|
Dec. 31, 2024
USD ($)
$ / shares
shares
|
Dec. 31, 2023
USD ($)
shares
|
Jun. 16, 2023
USD ($)
$ / shares
|
| ORGANIZATION AND BASIS OF PRESENTATION |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ordinary shares, par value | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
$ 0.0001
|
$ 0.0001
|
|
|
| Proceeds from exercise of warrants |
|
|
|
|
|
|
|
|
|
|
|
$ 102,993
|
$ 38,960
|
$ 21,652
|
|
| ADS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ORGANIZATION AND BASIS OF PRESENTATION |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Entity Listing, Depository Receipt Ratio |
|
|
|
|
|
|
1
|
|
|
|
1
|
1
|
|
|
|
| ADS | Representative Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ORGANIZATION AND BASIS OF PRESENTATION |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of ADS to purchase warrants | shares |
|
|
|
|
|
|
|
|
|
169,302
|
|
|
|
|
|
| Exercise price | $ / shares |
|
|
|
|
|
|
|
|
|
$ 7.5
|
|
|
|
|
|
| Ordinary Shares | April Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ORGANIZATION AND BASIS OF PRESENTATION |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price | $ / shares |
|
|
|
|
|
$ 44.14
|
|
|
|
|
|
|
|
|
|
| Aggregate amount of warrant | shares |
|
|
|
|
|
651,380
|
|
|
|
|
|
|
|
|
|
| Ordinary Shares | November Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ORGANIZATION AND BASIS OF PRESENTATION |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price | $ / shares |
|
|
|
|
|
$ 70
|
|
|
|
|
|
|
|
|
|
| Aggregate amount of warrant | shares |
|
|
|
|
|
651,380
|
|
|
|
|
|
|
|
|
|
| IPO | ADS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ORGANIZATION AND BASIS OF PRESENTATION |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued | shares |
|
|
|
|
|
|
|
|
|
6,000,000
|
|
|
|
|
|
| Offering price | $ / shares |
|
|
|
|
|
|
|
|
|
$ 6
|
|
|
|
|
|
| Entity Listing, Depository Receipt Ratio |
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
| Gross proceeds from issuance |
|
|
|
|
|
|
|
|
|
$ 36,000
|
|
|
|
|
|
| Net proceeds from issuance |
|
|
|
|
|
|
|
|
|
$ 33,705
|
|
|
|
|
|
| Over-Allotment Option |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ORGANIZATION AND BASIS OF PRESENTATION |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net proceeds from issuance |
|
|
|
|
|
|
|
|
|
|
$ 49,350
|
|
|
|
|
| Over-Allotment Option | ADS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ORGANIZATION AND BASIS OF PRESENTATION |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued | shares |
|
|
|
|
|
|
|
|
772,091
|
|
340,909
|
|
|
|
|
| Gross proceeds from issuance |
|
|
|
|
|
|
|
|
|
|
|
$ 52,500
|
|
|
|
| Net proceeds from issuance |
|
|
|
|
|
|
|
|
$ 4,285
|
|
|
|
|
|
|
| Follow-on offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ORGANIZATION AND BASIS OF PRESENTATION |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Offering price | $ / shares |
|
|
|
|
|
|
|
$ 15
|
|
|
|
|
|
|
|
| Net proceeds from issuance |
|
|
|
|
|
|
|
|
|
|
|
|
|
28,200
|
|
| Gross proceeds before underwriting discount |
|
|
|
|
|
|
|
$ 30,000
|
|
|
|
|
|
|
|
| Net proceeds before underwriting discount |
|
|
|
|
|
|
|
$ 27,317
|
|
|
|
|
|
|
|
| Follow-on offering | Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ORGANIZATION AND BASIS OF PRESENTATION |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price | $ / shares |
|
|
|
|
|
|
|
$ 18
|
|
|
|
|
|
|
|
| Aggregate amount of warrant | shares |
|
|
|
|
|
|
|
2,000,000
|
|
|
|
|
|
|
|
| Follow-on offering | ADS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ORGANIZATION AND BASIS OF PRESENTATION |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued | shares |
|
|
|
|
|
|
|
2,000,000
|
|
|
|
|
|
|
|
| Follow-on offering | Ordinary Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ORGANIZATION AND BASIS OF PRESENTATION |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued | shares |
|
|
|
|
|
|
|
2,000,000
|
|
|
|
|
|
|
|
| Ordinary shares, par value | $ / shares |
|
|
|
|
|
|
|
$ 0.0001
|
|
|
|
|
|
|
|
| At-the-Market offering ("ATM") |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ORGANIZATION AND BASIS OF PRESENTATION |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net proceeds from issuance |
|
|
|
|
|
|
|
|
|
|
|
$ 28,971
|
$ 16,474
|
$ 26,988
|
|
| At-the-Market offering ("ATM") | ADS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ORGANIZATION AND BASIS OF PRESENTATION |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued | shares |
|
|
|
|
|
|
|
|
|
|
|
193,000
|
284,719
|
731,843
|
|
| Entity Listing, Depository Receipt Ratio |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
| Gross proceeds from issuance |
|
|
|
|
|
|
|
|
|
|
|
$ 29,867
|
$ 16,984
|
$ 28,608
|
|
| Net proceeds from issuance |
|
|
|
|
|
|
|
|
|
|
|
28,971
|
$ 16,295
|
$ 27,403
|
|
| Aggregate offering price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 100,000
|
| At-the-Market offering ("ATM") | Ordinary Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ORGANIZATION AND BASIS OF PRESENTATION |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ordinary shares, par value | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
| Direct offering | ADS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ORGANIZATION AND BASIS OF PRESENTATION |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued | shares |
|
|
|
230,770
|
258,309
|
|
651,380
|
|
|
|
|
|
|
|
|
| Entity Listing, Depository Receipt Ratio |
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
| Gross proceeds from issuance |
|
|
|
$ 15,000
|
$ 15,000
|
|
$ 25,000
|
|
|
|
|
|
|
|
|
| Net proceeds from issuance |
|
|
|
|
$ 15,000
|
|
$ 24,811
|
|
|
|
|
|
|
|
|
| Exercise price | $ / shares |
|
|
|
$ 65.00
|
$ 58.07
|
|
|
|
|
|
|
|
|
|
|
| Aggregate amount of warrant | shares |
|
|
|
230,770
|
258,309
|
|
|
|
|
|
|
|
|
|
|
| Price per share | $ / shares |
|
|
|
$ 65
|
$ 58.07
|
|
$ 38.38
|
|
|
|
|
|
|
|
|
| Warrant term |
|
|
|
5 years
|
5 years
|
|
|
|
|
|
|
|
|
|
|
| Potential additional proceeds of from the exercise of issued in the offering |
|
|
|
$ 15,000
|
$ 15,000
|
|
|
|
|
|
|
|
|
|
|
| Direct offering | ADS | April Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ORGANIZATION AND BASIS OF PRESENTATION |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price | $ / shares |
|
|
|
|
|
|
$ 44.14
|
|
|
|
|
|
|
|
|
| Aggregate amount of warrant | shares |
|
|
|
|
|
|
651,380
|
|
|
|
|
|
|
|
|
| Warrant term |
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
| Direct offering | Ordinary Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ORGANIZATION AND BASIS OF PRESENTATION |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price | $ / shares |
|
|
|
|
|
|
$ 44.14
|
|
|
|
|
|
|
|
|
| Aggregate amount of warrant | shares |
|
|
|
|
|
|
651,380
|
|
|
|
|
|
|
|
|
| Private placement in public equity financing |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ORGANIZATION AND BASIS OF PRESENTATION |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued | shares |
|
1,953,124
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Offering price | $ / shares |
|
$ 64
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gross proceeds from issuance |
|
|
$ 125,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net proceeds from issuance |
|
|
|
|
|
|
|
|
|
|
|
$ 125,000
|
|
|
|
| Exercise price | $ / shares |
|
$ 76.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate amount of warrant | shares |
|
1,953,124
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant term |
|
2 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Potential additional proceeds of from the exercise of issued in the offering |
|
|
$ 150,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Agreement For Exercise Of Warrants | April Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ORGANIZATION AND BASIS OF PRESENTATION |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price | $ / shares |
|
|
|
|
|
$ 44.14
|
|
|
|
|
|
|
|
|
|
| Aggregate amount of warrant | shares |
|
|
|
|
|
651,380
|
|
|
|
|
|
|
|
|
|
| Proceeds from exercise of warrants |
|
|
|
|
|
$ 28,752
|
|
|
|
|
|
|
|
|
|
| Agreement For Exercise Of Warrants | November Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ORGANIZATION AND BASIS OF PRESENTATION |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price | $ / shares |
|
|
|
|
|
$ 70
|
|
|
|
|
|
|
|
|
|
| Aggregate amount of warrant | shares |
|
|
|
|
|
651,380
|
|
|
|
|
|
|
|
|
|
| Warrant term |
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
| Proceeds from exercise of warrants |
|
|
|
|
|
$ 45,597
|
|
|
|
|
|
|
|
|
|
| Underwritten Public Offering | ADS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ORGANIZATION AND BASIS OF PRESENTATION |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued | shares |
2,272,727
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Entity Listing, Depository Receipt Ratio |
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gross proceeds from issuance |
$ 350,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net proceeds from issuance |
$ 328,117
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Price per share | $ / shares |
$ 154
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Underwriters option period |
30 days
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Additional ADS | shares |
340,909
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Belite Bio Holdings Corp.("Belite Holding") |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ORGANIZATION AND BASIS OF PRESENTATION |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ownership interest (in percent) |
|
|
|
|
|
|
|
|
|
|
100.00%
|
100.00%
|
|
|
|
| Belite Bio, LLC("Belite USA") | Belite Bio Holdings Corp.("Belite Holding") |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ORGANIZATION AND BASIS OF PRESENTATION |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ownership interest (in percent) |
|
|
|
|
|
|
|
|
|
|
100.00%
|
100.00%
|
|
|
|
| RBP4 Pty Ltd("RBP4") | Belite Bio Holdings Corp.("Belite Holding") |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ORGANIZATION AND BASIS OF PRESENTATION |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ownership interest (in percent) |
|
|
|
|
|
|
|
|
|
|
100.00%
|
100.00%
|
|
|
|
| Belite Bio (HK) Limited("Belite HK") |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ORGANIZATION AND BASIS OF PRESENTATION |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ownership interest (in percent) |
|
|
|
|
|
|
|
|
|
|
100.00%
|
100.00%
|
|
|
|
| Belite Bio (Shanghai) Limited ("Belite Shanghai") | Belite Bio (HK) Limited("Belite HK") |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ORGANIZATION AND BASIS OF PRESENTATION |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ownership interest (in percent) |
|
|
|
|
|
|
|
|
|
|
100.00%
|
100.00%
|
|
|
|
| Belite Bio (Taiwan) Inc | Belite Bio (HK) Limited("Belite HK") |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ORGANIZATION AND BASIS OF PRESENTATION |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ownership interest (in percent) |
|
|
|
|
|
|
|
|
|
|
100.00%
|
100.00%
|
|
|
|
| Belite Bio (Swiss) AG | Belite Bio (HK) Limited("Belite HK") |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ORGANIZATION AND BASIS OF PRESENTATION |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ownership interest (in percent) |
|
|
|
|
|
|
|
|
|
|
100.00%
|
100.00%
|
|
|
|
| Belite Bio Japan Inc | Belite Swiss |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ORGANIZATION AND BASIS OF PRESENTATION |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ownership interest (in percent) |
|
|
|
|
|
|
|
|
|
|
100.00%
|
100.00%
|
|
|
|